Effects of a clinical pathway on antibiotic use in patients with community-acquired pneumonia: a multi-site study in China

Table 3 Multivariate logistic analysis of overall compliance with antibiotic use ^a

Parameters	OR Estimates	95% CI ^b		p-value
Parameters	OR Estimates	Lower	Upper	p-value
Intercept				0.760
Regions (comparison = Shanghai)
Hubei province (1 = yes, 0 = no)	0.31	0.20	0.48	< 0.0001
Gansu province (1 = yes, 0 = no)	0.26	0.16	0.41	< 0.0001
Tertiary hospital (1 = yes, 0 = no)	0.73	0.50	1.07	0.108
Male (1 = yes, 0 = no)	0.93	0.64	1.35	0.699
Age (years)	1.01	1.00	1.02	0.184
No. of comorbidities (comparison = 0)
1 comorbidity (1 = yes, 0 = no)	0.83	0.54	1.29	0.410
2 comorbidities (1 = yes, 0 = no)	1.05	0.60	1.83	0.871
Non-severe CAP (1 = yes, 0 = no)	0.85	0.54	1.32	0.463
Hospital implementation of CP (1 = yes, 0 = no)	1.76	1.16	2.71	0.009

^aThe dependent variable was overall compliance with antibiotic use in inpatients with CAP (1: overall compliance; 0: overall non-compliance), and χ²_{likelihood ratio} = 67.66, p < 0.001;
^bCI: Confidence interval

ISSN: 1471-2334